Does ngvt stock pay a dividend?
Mar 25, 2022 · 4 equities research analysts have issued 1-year target prices for Ingevity's shares. Their forecasts range from $81.00 to $112.00. On average, they expect Ingevity's stock price to reach $93.00 in the next twelve months. This suggests a possible upside of 49.2% from the stock's current price.
Is Ingevity Corporation's (ngvt) sustainability rating good?
102 rows · Discover historical prices for NGVT stock on Yahoo Finance. View daily, weekly or monthly format back to when Ingevity Corporation stock was issued.
What is the upside for Ingevity's share price?
Apr 08, 2022 · According to 14 analysts, the average rating for NGVT stock is "Buy." The 12-month stock price forecast is 91.29, which is an increase of 46.34% from the latest price.
How has covid-19 affected Ingevity's stock?
View the latest Ingevity Corp. (NGVT) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Is Ingevity a good stock to buy?
Ingevity Corporation - Buy Valuation metrics show that Ingevity Corporation may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of NGVT, demonstrate its potential to outperform the market. It currently has a Growth Score of B.
Is Ingevity a public company?
NORTH CHARLESTON, S.C., May 16, 2016 (BUSINESS WIRE) – Ingevity Corporation (NYSE: NGVT) announced today that it has begun operations as a standalone, publicly traded company, following a tax-free spinoff from WestRock Company (NYSE: WRK).May 16, 2016
What kind of company is Ingevity?
specialty chemicalsIngevity is the specialty chemicals division of WestRock, formerly MeadWestvaco, and is a leading global manufacturer of specialty chemicals and high-performance carbon materials headquartered in North Charleston, S.C.May 16, 2016
What was Ingevity before?
Dear Future Ingevity Stockholder: It is our pleasure to welcome you as a stockholder of Ingevity Corporation, formerly the specialty chemicals business of WestRock Company. Ingevity is a leading global manufacturer of specialty chemicals and high performance carbon materials.
Is Ingevity a buy right now?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last twelve months. There are currently 2 hold ratings and...
How has Ingevity's stock been impacted by COVID-19?
Ingevity's stock was trading at $38.80 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO)....
When is Ingevity's next earnings date?
Ingevity is scheduled to release its next quarterly earnings announcement on Wednesday, April 27th 2022. View our earnings forecast for Ingevity .
How were Ingevity's earnings last quarter?
Ingevity Co. (NYSE:NGVT) announced its earnings results on Wednesday, February, 23rd. The company reported $0.78 EPS for the quarter, meeting the T...
What guidance has Ingevity issued on next quarter's earnings?
Ingevity issued an update on its FY 2022 earnings guidance on Wednesday, March, 16th. The company provided EPS guidance of for the period. The comp...
What price target have analysts set for NGVT?
4 brokers have issued 1 year price targets for Ingevity's stock. Their forecasts range from $81.00 to $112.00. On average, they expect Ingevity's s...
Who are Ingevity's key executives?
Ingevity's management team includes the following people: John C. Fortson , President, CEO, Treasurer & Director Marty Heyne , Senior Vice Presi...
What is John Fortson's approval rating as Ingevity's CEO?
2 employees have rated Ingevity CEO John Fortson on Glassdoor.com . John Fortson has an approval rating of 100% among Ingevity's employees. This p...
Who are some of Ingevity's key competitors?
Some companies that are related to Ingevity include Huntsman (HUN) , Olin (OLN) , Univar Solutions (UNVR) , Ashland Global (ASH) , Johnson Mat...
Is Ingevity a buy right now?
What stocks does MarketBeat like better than Ingevity?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 2 buy ratings for the stock.
Are investors shorting Ingevity?
Wall Street analysts have given Ingevity a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ingevity wasn't one of them.
When is Ingevity's next earnings date?
Ingevity saw a drop in short interest in the month of August. As of August 13th, there was short interest totaling 839,600 shares, a drop of 17.7% from the July 29th total of 1,020,000 shares. Based on an average daily volume of 206,700 shares, the short-interest ratio is presently 4.1 days.
How were Ingevity's earnings last quarter?
Ingevity is scheduled to release its next quarterly earnings announcement on Tuesday, October 19th 2021.#N#View our earnings forecast for Ingevity.
How has Ingevity's stock price been impacted by COVID-19 (Coronavirus)?
Ingevity Co. (NYSE:NGVT) issued its quarterly earnings data on Wednesday, July, 28th. The company reported $1.55 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.21 by $0.34. The company had revenue of $358.40 million for the quarter, compared to analysts' expectations of $331.55 million.
What guidance has Ingevity issued on next quarter's earnings?
Ingevity's stock was trading at $38.80 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NGVT shares have increased by 89.8% and is now trading at $73.64.#N#View which stocks have been most impacted by COVID-19.
Ingevity announces details for upcoming webinar on the outlook for pine chemicals and rosin industry dynamics
Ingevity updated its FY 2021 earnings guidance on Wednesday, August, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.32 billion-$1.36 billion, compared to the consensus revenue estimate of $1.33 billion.
Ingevity (NGVT) Upgraded to Buy: What Does It Mean for the Stock?
NORTH CHARLESTON, S.C.-- (BUSINESS WIRE)--Ingevity announced that it will hold a live webinar to discuss the outlook for pine chemicals and rosin industry dynamics at 10 a.m. on August 25.
Ingevity's (NGVT) Earnings and Sales Top Estimates in Q2
Ingevity (NGVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ingevity (NGVT) Q2 Earnings and Revenues Beat Estimates
Ingevity (NGVT) benefits from higher demand and price increases across its business in the second quarter.
Ingevity reports second quarter 2021 financial results and increases full year 2021 guidance
Ingevity (NGVT) delivered earnings and revenue surprises of 28.10% and 8.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Ingevity (NGVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
NORTH CHARLESTON, S.C.-- (BUSINESS WIRE)--Ingevity Corporation reported its second quarter 2021 financial results.
Here's Why You Should Buy Ingevity (NGVT) Stock Right Now
Ingevity (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to calculate restricted stock?
Ingevity (NGVT) gains from acquisitions, increased sales in China and a rise in automotive-based activated carbon sales.
How long are futures trading delayed?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
How to calculate P/E?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
Signals & Forecast
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The NGVT stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Is NGVT stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
NGVT Overview
NGVT holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Share Price & News
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America.
Valuation
How has Ingevity's share price performed over time and what events caused price changes?
Future Growth
Is Ingevity undervalued compared to its fair value and its price relative to the market?
Dividend
How is Ingevity forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Management
What is Ingevity current dividend yield, its reliability and sustainability?
Ownership
How experienced are the management team and are they aligned to shareholders interests?
